Cita APA

Jhaveri, K., Loi, S., Bardia, A., Bellet Ezquerra, M., Turner, N., & Boni, v. (2024). Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer.

Citación estilo Chicago

Jhaveri, Komal, Sherene Loi, Aditya Bardia, Meritxell Bellet Ezquerra, Nicholas Turner, y valentina Boni. Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer. 2024.

Cita MLA

Jhaveri, Komal, et al. Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer. 2024.